Durmo, R.; Filice, A.; Fioroni, F.; Cervati, V.; Finocchiaro, D.; Coruzzi, C.; Besutti, G.; Fanello, S.; Frasoldati, A.; Versari, A.
Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT. Cancers 2022, 14, 592.
https://doi.org/10.3390/cancers14030592
AMA Style
Durmo R, Filice A, Fioroni F, Cervati V, Finocchiaro D, Coruzzi C, Besutti G, Fanello S, Frasoldati A, Versari A.
Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT. Cancers. 2022; 14(3):592.
https://doi.org/10.3390/cancers14030592
Chicago/Turabian Style
Durmo, Rexhep, Angelina Filice, Federica Fioroni, Veronica Cervati, Domenico Finocchiaro, Chiara Coruzzi, Giulia Besutti, Silvia Fanello, Andrea Frasoldati, and Annibale Versari.
2022. "Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT" Cancers 14, no. 3: 592.
https://doi.org/10.3390/cancers14030592
APA Style
Durmo, R., Filice, A., Fioroni, F., Cervati, V., Finocchiaro, D., Coruzzi, C., Besutti, G., Fanello, S., Frasoldati, A., & Versari, A.
(2022). Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT. Cancers, 14(3), 592.
https://doi.org/10.3390/cancers14030592